These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 11505526)
1. [Light and shade on the treatment of HIV infection]. Takata N Rinsho Ketsueki; 2001 Jun; 42(6):476-80. PubMed ID: 11505526 [No Abstract] [Full Text] [Related]
2. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related]
3. Intention-to-treat analysis of anti-HIV therapies and incidence of drug resistance after a year of treatment. Aizawa S; Ida S; Sakai-Hachiya A; Tanaka M; Takahashi Y; Hirabayashi Y; Sugiura W; Kimura S; Oka S Jpn J Infect Dis; 1999 Jun; 52(3):129-31. PubMed ID: 10507996 [No Abstract] [Full Text] [Related]
4. [Incorporation of the test of resistance to antiretroviral drugs in clinical practice]. Soriano V; Briones C Med Clin (Barc); 1999 Mar; 112(11):412-5. PubMed ID: 10231774 [No Abstract] [Full Text] [Related]
6. HIV drug resistance testing: data be damned. Res Initiat Treat Action; 2000 Dec; 6(4):25-7. PubMed ID: 11708172 [No Abstract] [Full Text] [Related]
7. [Resistance investigations during HIV-therapy is necessary]. Schattenfroh S Dtsch Med Wochenschr; 1998 Feb; 123(7):A7. PubMed ID: 9505940 [No Abstract] [Full Text] [Related]
8. HIV drug resistance testing: an update for the clinician. Rice HL; Zolopa AR AIDS Clin Care; 2001 Oct; 13(10):89-91, 94-6, 100. PubMed ID: 11590921 [No Abstract] [Full Text] [Related]
9. The next big challenge: managing HIV infection in an age of higher resistance. AIDS Alert; 2001 Dec; 16(12):153, 155-7. PubMed ID: 11768873 [No Abstract] [Full Text] [Related]
17. Relationship between drug resistance mutations, plasma viremia, and CD4+ T-cell counts in patients with chronic HIV infection. de Mendoza C; Martín-Carbonero L; Gallego O; Corral A; González-Lahoz J; Soriano V J Med Virol; 2005 May; 76(1):1-6. PubMed ID: 15778973 [TBL] [Abstract][Full Text] [Related]
18. Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure. Lohse N; Jørgensen LB; Kronborg G; Møller A; Kvinesdal B; Sørensen HT; Obel N; Gerstoft J; Antivir Ther; 2007; 12(6):909-17. PubMed ID: 17926645 [TBL] [Abstract][Full Text] [Related]